Agios Pharmaceuticals: Q2 Earnings Snapshot

CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Agios Pharmaceuticals Inc. (AGIO) on Thursday reported a loss of $83.8 million in its second quarter.

The Cambridge, Massachusetts-based company said it had a loss of $1.51 per share.

The results beat Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of $1.60 per share.

The biopharmaceutical company posted revenue of $6.7 million in the period, which matched Street forecasts.

Agios Pharmaceuticals shares have dropped 7.5% since the beginning of the year. The stock has climbed 13% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AGIO at https://www.zacks.com/ap/AGIO